Haffner retiring from FDA to join Amgen

Share this content:
The FDA's director of orphan products development for the past 19 years, Marlene Haffner, will retire in January to join the biotech firm Amgen as director of its government affairs office in Washington.
Share this content:
Scroll down to see the next article